Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastasis Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07376629
What this trial is testing

HB0025 Plus Nab-paclitaxel as First Line Therapy for TNBC

Who this might be right for
TNBC
Huabo Biopharm Co., Ltd. 60
Early research (Phase 1)Looking for participantsNCT06010862
What this trial is testing

Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors

Who this might be right for
Gastric CancerColon CancerPancreas Cancer+4 more
Chongqing Precision Biotech Co., Ltd 36
Not applicableLooking for participantsNCT06896162
What this trial is testing

PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival

Who this might be right for
Solid Tumor MalignanciesMetastatic CancerBreast Cancer+3 more
UNC Lineberger Comprehensive Cancer Center 500
Testing effectiveness (Phase 2)Study completedNCT00006370
What this trial is testing

Radiolabeled SMT-487 (Yttrium Y 90-DOTA-tyr3-octreotide) in Treating Patients With Refractory Small Cell Lung Cancer or Metastatic Breast Cancer

Who this might be right for
Breast CancerLung Cancer
Novartis Pharmaceuticals 275
Testing effectiveness (Phase 2)Study completedNCT00024154
What this trial is testing

Trastuzumab and Gefitinib in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Male Breast CancerRecurrent Breast CancerStage IV Breast Cancer
National Cancer Institute (NCI) 132
Testing effectiveness (Phase 2)UnknownNCT05823623
What this trial is testing

Inetetamab Combined With Pyrotinib Plus Oral Vinorelbine for the Treatment of HER2-positive Metastatic Breast Cancer

Who this might be right for
Breast Cancer
The First Affiliated Hospital with Nanjing Medical University 30
Not applicableUnknownNCT06135194
What this trial is testing

Efficacy of T-Dxd in the Treatment of HER2-positive BCBM After Prior Pyrotinib

Who this might be right for
Breast Cancer
Beijing 302 Hospital 30
Not applicableUnknownNCT02642458
What this trial is testing

Pertuzumab in First Line Treatment of HER2-positive Metastatic Breast Cancer Patients

Who this might be right for
Metastatic Breast Cancer
University Hospital Tuebingen 300
Testing effectiveness (Phase 2)Ended earlyNCT02984683
What this trial is testing

Study Evaluating Efficacy and Safety of SAR566658 Treatment in Patients With CA6 Positive Metastatic Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Sanofi 23
Early research (Phase 1)Study completedNCT02254005
What this trial is testing

Single Dose Escalation Study of Bivatuzumab Mertansine in Female Patients With CD44v6 Positive Metastatic Breast Cancer

Who this might be right for
Breast Neoplasms
Boehringer Ingelheim 24
Not applicableUnknownNCT05760183
What this trial is testing

Discovering Factors in Metastatic Breast Cancer Patients' Clinical Trial Experiences

Who this might be right for
Metastatic Breast Cancer
Power Life Sciences Inc. 500
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06586866
What this trial is testing

JK-1201I in Triple Negative Breast Cancer Patients with Brain Metastases

Who this might be right for
Triple Negative Breast Cancer (TNBC)Brain Metastasases
JenKem Technology Co., Ltd. 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07630103
What this trial is testing

Efficacy and Safety of Trastuzumab Rezetecan or Trastuzumab Deruxtecan in Advanced Breast Cancer

Who this might be right for
Advanced Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 100
Early research (Phase 1)Study completedNCT00508586
What this trial is testing

PTC299 and Hormonal Agent for Treatment of Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
PTC Therapeutics 33
Not applicableUnknownNCT01224873
What this trial is testing

Diagnosis of Bone Metastases in Breast Cancer: Bone Scintigraphy, Fluoride-PET and FDG-PET

Who this might be right for
Breast Cancer
Rigshospitalet, Denmark 110
Post-approval studies (Phase 4)Study completedNCT01907880
What this trial is testing

The ODYSSEY TRIAL Phase IV Trial Evaluating the Palliative Benefit of Pamidronate or Zoledronic Acid in Breast Cancer

Who this might be right for
Breast Cancer
Ottawa Hospital Research Institute 74
Large-scale testing (Phase 3)UnknownNCT02394496
What this trial is testing

Overcoming Endocrine Resistance in Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Consorzio Oncotech 396
Very early researchUnknownNCT05680662
What this trial is testing

The Study of Quadruple Therapy Quercetin, Zinc, Metformin, and EGCG as Adjuvant Therapy for Early, Metastatic Breast Cancer and Triple-negative Breast Cancer, a Novel Mechanism

Who this might be right for
Breast Cancer FemaleTriple Negative Breast Cancer
Ministry of Health, Saudi Arabia 200
Next Page